More information has emerged about “COVID arm” — a delayed arm rash appearing after Moderna’s COVID-19 vaccine is administered — including likelihood, duration and treatment. Researchers examined 16 ...
The new study, spearheaded by experts at UCL and the universities of Cambridge and Edinburgh, with support from the BHF Data ...
Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID vaccine, but only for specific populations: all adults 65 and over and those ...